Sony PlayStation 5 Release Date, Price, Specs: How Much the Next-Generation Could Cost in 2020 
MacBook Pro 2019 Review: How Different is the Current Model to the 2018 Variant? 
Cancer Cure 2019: Immunotherapy Drug Under Research Shows Promising Result for Lung Cancer Patients 
GoPro Hero 8 Release Date: What Improvements Should the Eight Entry Focus On? 
‘Apex Legends’ Season 2 Release Date: New Characters, Guns, and More to be Introduced on July 2 
‘Cyberpunk 2077’ Release Date, Latest News: Mission Lengths, Depth Explain by Lead Quest Designer 
HIV/AIDS Cure 2019: Scientists May Have Found a Way to End HIV Transmission 
‘The Last of Us Part 2’ Release Date: Sequel Rumored to Come out in February 2020; How Likely Is It? 
Meet the naked mole-rat: impervious to pain and cancer, and lives ten times longer than it should 
Cancer Cure Found in Ancient Fish? Study Leans on to Parasitic Eel-Like Fish for Better Brain Cancer Treatment 
Libra: four reasons to be extremely cautious about Facebook's new currency 
Vladimir Putin's U.S. Relationship Turns Sour 'By the Hour' While He Shares Sweet Dessert With Xi Jinping 
'NBA 2K20' Release Date, Gameplay: Will the Official Announcement Happen in July? 
AMD Radeon 5700 XT Release Date, Latest News: Team Red Eyeing to Dominate High-End Mid-Range Market 
iOS 13 Release Date, Features: How to Join Public Beta and Other Important Reminders 
Windows 10 Bugs: How to Resolve 'Black Screen' Issue in June Patch 
- News
- Economy
- Central Banks
- Investing
- Research
- Roundups
- Digital Currency
- Insights
- Technical Analysis
- Technology
- Business
- Law
- Health
- Nature
- Fintech
- Science
- Topic
- Opinions
- EconoTimes PRO
- ©Elmin Media . All Rights Reserved.
Automation Takes Over Stem Cell Manufacturing Too, FDA Approves
Stem Cell Illustration.PublicDomainPictures/Pixabay
When discussing stem cell research, most people would likely bring up scientists harvesting stem cells from living tissue. While this is certainly true, there is now a new method that would allow researchers to manufacture stem cells so that they have much more of it to work with. The U.S. Food and Drug Administration (FDA) recently approved the process employed by the Mayo Clinic, which actually automates the process.
In a press release, the Mayo Clinic describes both the process and implications of the FDA approval to stem cell research. Apparently, this allows the researchers to take the bone marrow of a donor and then produce a much higher quantity of stem cells that will then be used to advance research in regenerative medicine.
According to the medical director of Transfusion Medicine and the Human Cell Therapy Laboratory, Abba Zubair, this process is a huge boon for cases where the patient’s own stem cells are not enough to allow for treatment. These cases can often be a problem, mostly because harvesting stem cells is not exactly that easy.
“This may make treatments possible in cases where the patient’s own cells are not viable as therapy,” Dr. Zubair said. “In addition, because the cells can be produced in days instead of months, it may also make treatments available on short notice when they’re needed for acute care.”
As Futurism notes, stem cell research has already proven promising in a variety of treatment cases, addressing everything from arthritis to paralysis. By cranking up production of stem cells via an automated production method, not only will researchers have significantly more batches to work with, patients won’t have to wait for months to be treated.
On a side note, this process also highlights the huge advantages to automating the manufacturing process in the field of research and medicine. In these areas, robots are just taking over, and that might be for the best.
Editor's Picks
June 26 21:00 UTC Released
KRBOK Manufacturing BSI
Actual
76 Bln BRL
Forecast
Previous
72 Bln BRL
June 26 19:00 UTC Released
ARTrade Balance
Actual
1373 %
Forecast
850 %
Previous
1131 %
January 31 00:00 UTC 737160m
ARAnnual Primary Balance*
Actual
Forecast
2016 bln ARS
Previous
Bln AR bln ARS
January 31 00:00 UTC 737160m
ARAnnual Primary Balance*
Actual
Forecast
2016 bln ARS
Previous
Bln AR bln ARS
January 22 19:00 UTC 748980m
ARTrade Balance
Actual
Forecast
Previous
-1541 %
January 31 00:00 UTC 737160m
ARAnnual Primary Balance*
Actual
Forecast
2016 bln ARS
Previous
Bln AR bln ARS
January 22 19:00 UTC 748980m
ARTrade Balance
Actual
Forecast
Previous
-1541 %
January 31 00:00 UTC 737160m
ARAnnual Primary Balance*
Actual
Forecast
2016 bln ARS
Previous
Bln AR bln ARS
January 31 00:00 UTC 737160m
ARAnnual Primary Balance*
Actual
Forecast
2016 bln ARS
Previous
Bln AR bln ARS
January 31 00:00 UTC 737160m
ARAnnual Primary Balance*
Actual
Forecast
2016 bln ARS
Previous
Bln AR bln ARS
